Prelude Capital Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-26,667
| Closed | -$521K | – | 1261 |
|
|
2024
Q3 | $521K | Buy |
26,667
+2,967
| +13% | +$58K | 0.03% | 542 |
|
|
2024
Q2 | $488K | Buy |
+23,700
| New | +$488K | 0.03% | 491 |
|
|
2021
Q1 | – | Sell |
-14,391
| Closed | -$470K | – | 1258 |
|
|
2020
Q4 | $470K | Buy |
14,391
+11,003
| +325% | +$359K | 0.01% | 385 |
|
|
2020
Q3 | $104K | Buy |
+3,388
| New | +$104K | 0.01% | 670 |
|
|
2018
Q1 | – | Sell |
-900
| Closed | -$14K | – | 1457 |
|
|
2017
Q4 | $14K | Sell |
900
-900
| -50% | -$14K | ﹤0.01% | 1039 |
|
|
2017
Q3 | $27K | Buy |
+1,800
| New | +$27K | ﹤0.01% | 1138 |
|
|
2016
Q1 | – | Sell |
-400
| Closed | -$3K | – | 1315 |
|
|
2015
Q4 | $3K | Buy |
+400
| New | +$3K | ﹤0.01% | 1290 |
|